COVID-19 is impacting millions of people worldwide from all different backgrounds and health statuses, said Verilys chief medical and scientific officer, Jessica Mega, M.D. We anticipate learnings from the study will help to better inform future treatment and prevention practices as the world co
Date: Feb 08, 2021
Category: More news
Source: Google
Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions
with clinicians, and the company is learning to decide where the traditional vigor of a clinical trial is needed and when it should apply the creativity, innovation, and feedback associated with the technology giant. These ways are merging, Verily CMO Jessica Mega told attendees at WinterTech.
Date: Jan 12, 2017
Category: Health
Source: Google
Beyond Fitbit: The quest to develop medical-grade wearables
also chasing medical wearables. Dr. Jessica Mega, a former Harvard cardiologist who is now chief medical officer at Alphabet Inc.s health care unit Verily, said at a recent digital health conference that the company plans to work closely with the FDA as it develops its own medical-grade devices.
Date: Dec 20, 2015
Category: Health
Source: Google
Beyond Fitbit: The quest to develop medical-grade wearables
are also chasing medical wearables. Dr. Jessica Mega, a former Harvard cardiologist who is now chief medical officer at Alphabet Inc's healthcare unit Verily, said at a recent digital health conference that the company plans to work closely with the FDA as it develops its own medical-grade devices.
With a maintenance dose of 225 mg daily, patients who had one copy of an allele that confers resistance to clopidogrel were able to achieve levels of platelet reactivity similar to those of patients who responded to the standard 75-mg dose, according to Jessica Mega, MD, of Brigham and Women's Hospi
Date: Nov 16, 2011
Category: Health
Source: Google
Genetic tests can predict who needs higher doses of Plavix
Yet nearly one-third of heart patients have genes that can prevent them from properly processing the drug, says cardiologist Jessica Mega, author of the study presented today at the annual meeting of the American Heart Association in Orlando.
Date: Nov 16, 2011
Category: Health
Source: Google
Blood thinner drug lowers long-term risk of death in heart attack patients
rventional cardiologist at Brigham and Womens Hospital. His co-author Dr. Jessica Mega, also at the Brigham, agreed, saying, Its really exciting to think about a new treatment strategy since 10 percent of heart attack patients wind up having another heart attack with the current therapies.
Some cardiologists said it's too early to declare a winner among the new agents. "Aristotle is a great result and there's going to be a lot of enthusiasm," said Jessica Mega, a cardiologist at Brigham and Women's Hospital in Boston. While the absolute reduction in serious events was smallfor every